Compounds > 1-(4-isothiocyanatobenzyl)diethylenetriaminepentaacetic acid
Page last updated: 2024-09-03

1-(4-isothiocyanatobenzyl)diethylenetriaminepentaacetic acid and rhenium

1-(4-isothiocyanatobenzyl)diethylenetriaminepentaacetic acid has been researched along with rhenium in 1 studies

Compound Research Comparison

Studies
(1-(4-isothiocyanatobenzyl)diethylenetriaminepentaacetic acid)		Trials
(1-(4-isothiocyanatobenzyl)diethylenetriaminepentaacetic acid)		Recent Studies (post-2010)
(1-(4-isothiocyanatobenzyl)diethylenetriaminepentaacetic acid)		Studies
(rhenium)		Trials
(rhenium)		Recent Studies (post-2010) (rhenium)
13012,106111774

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boerman, OC; Brouwers, AH; Corstens, FH; Frielink, C; Oosterwijk, E; Oyen, WJ; van Eerd, JE1

Other Studies

1 other study(ies) available for 1-(4-isothiocyanatobenzyl)diethylenetriaminepentaacetic acid and rhenium

ArticleYear
Optimization of radioimmunotherapy of renal cell carcinoma: labeling of monoclonal antibody cG250 with 131I, 90Y, 177Lu, or 186Re.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2004, Volume: 45, Issue:2

    Topics: Animals; Antibodies, Monoclonal; Carcinoma, Renal Cell; Humans; Iodine Radioisotopes; Isotope Labeling; Kidney Neoplasms; Lutetium; Mice; Mice, Nude; Pentetic Acid; Radioimmunotherapy; Radioisotopes; Rhenium; Tissue Distribution; Yttrium Radioisotopes

2004